AliquantumRx Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Upcoming)

  • Latest Deal Amount
  • $750K

  • Investors
  • 3

AliquantumRx General Information

Description

Developer of a macrolide antibiotic platform designed to advance novel therapeutic applications across multiple high-impact disease areas. The company offers Cethromycin-HCl for use in treating dormant liver-stage malaria, tick-borne Babesiosis, drug-resistant bacterial infections, and biodefense threats such as inhalation anthrax and pneumonic plague, enabling healthcare providers to address unmet needs in infectious disease and biodefense with a single, promising therapeutic candidate.

Contact Information

Formerly Known As
Quantum-Biosciences
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1812 Ashland Avenue
  • Suite 100
  • Baltimore, MD 21205
  • United States
+1 (202)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1812 Ashland Avenue
  • Suite 100
  • Baltimore, MD 21205
  • United States
+1 (202)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AliquantumRx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC $750K Upcoming Clinical Trials - Phase 2
6. Grant Completed Pre-Clinical Trials
5. Secondary Transaction - Private Completed Pre-Clinical Trials
4. Grant 02-Jul-2019 Completed Pre-Clinical Trials
3. Early Stage VC 25-Jan-2019 Completed Product Development
2. Accelerator/Incubator 14-Jan-2019 $400K Completed Product Development
1. Angel (individual) 01-Jan-2019 $400K $400K Completed Product Development
To view AliquantumRx’s complete valuation and funding history, request access »

AliquantumRx Patents

AliquantumRx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11697667-B2 Salts and polymorphs of cethromycin for the treatment of disease Active 02-Dec-2019
US-12391720-B2 Salts and polymorphs of cethromycin for the treatment of disease Active 02-Dec-2019
US-20210163522-A1 Salts and polymorphs of cethromycin for the treatment of disease Active 02-Dec-2019
US-20230312633-A1 Salts and polymorphs of cethromycin for the treatment of disease Active 02-Dec-2019
US-20250340583-A1 Salts and polymorphs of cethromycin for the treatment of disease Pending 02-Dec-2019 C07H17/08
To view AliquantumRx’s complete patent history, request access »

AliquantumRx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AliquantumRx Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
TEDCO Venture Capital Minority
Johns Hopkins Technology Ventures Accelerator/Incubator Minority
Triangle Angel Partners Angel Group Minority
To view AliquantumRx’s complete investors history, request access »

AliquantumRx FAQs

  • When was AliquantumRx founded?

    AliquantumRx was founded in 2016.

  • Where is AliquantumRx headquartered?

    AliquantumRx is headquartered in Baltimore, MD.

  • What is the size of AliquantumRx?

    AliquantumRx has 6 total employees.

  • What industry is AliquantumRx in?

    AliquantumRx’s primary industry is Drug Discovery.

  • Is AliquantumRx a private or public company?

    AliquantumRx is a Private company.

  • What is AliquantumRx’s current revenue?

    The current revenue for AliquantumRx is .

  • How much funding has AliquantumRx raised over time?

    AliquantumRx has raised $900K.

  • Who are AliquantumRx’s investors?

    TEDCO, Johns Hopkins Technology Ventures, and Triangle Angel Partners have invested in AliquantumRx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process